1. Academic Validation
  2. Stereoselective Degradation of Diacylglycerol Kinases Potentiate T cell Activation and Tumor Cell Cytotoxicity

Stereoselective Degradation of Diacylglycerol Kinases Potentiate T cell Activation and Tumor Cell Cytotoxicity

  • bioRxiv. 2025 Dec 12:2025.12.09.692983. doi: 10.64898/2025.12.09.692983.
Minhaj Shaikh 1 Surya Pravo Mookherjee 1 Claire C Weckerly 2 Adam H Libby 3 4 Aizhen Xiao 5 Yunge Zhao 5 Sagar D Vaidya 1 AeRyon Kim 6 Zhihong Li 1 Madeleine L Ware 1 Michelle Marants 1 Olivia L Murtagh 1 Wesley J Wolfe 1 Timothy Nj Bullock 6 Benjamin W Purow 5 Gerald R V Hammond 2 Ku-Lung Hsu 1
Affiliations

Affiliations

  • 1 Department of Chemistry, University of Texas at Austin, Austin, TX, 78712, USA.
  • 2 Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
  • 3 Department of Chemistry, University of Virginia, Charlottesville, VA 22904, USA.
  • 4 Drug Discovery Center, UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA, 22904, USA.
  • 5 Department of Neurology, University of Virginia, Charlottesville, VA 22908, USA.
  • 6 Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA.
Abstract

Stereoselective recognition is a powerful means to differentiate selective versus non-specific activity of small molecules in complex biological systems. Here, we disclose stereochemically defined, sulfonyltriazole inhibitors of the lipid enzyme diacylglycerol kinase-alpha (DGKα), a key metabolic checkpoint for T cell effector function. Acute treatment with the covalent DGKα inhibitor AHL-7160 recruited endogenous DGKα to the plasma membrane in a stereoselective and isozyme-specific manner. The membrane translocation activity of AHL-7160 correlated with blockade of cellular phosphatidic acid production and potentiation of primary T cell-mediated killing of a glioblastoma cell line. Quantitative chemoproteomics revealed Y669 and K411 as sites of AHL-7160 modification on endogenous DGKα in cells. Extended treatments resulted in proteasome-dependent and proteome-wide selective degradation of DGKα in T cells. Collectively, these findings establish covalent DGKα ligands as potent Molecular Glues with translational potential in immunotherapy.

Figures
Products